Tarsus Pharmaceuticals, Inc. TARS Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s net change in cash?
- Tarsus Pharmaceuticals, Inc. (TARS) reported net change in cash of -$82.01M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s net change in cash decreased by 201.3% year-over-year, from $80.97M to -$82.01M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s net change in cash?
- Over 2 years (2022 to 2024), Tarsus Pharmaceuticals, Inc.'s net change in cash has grown at a 13.1% compound annual growth rate (CAGR), from -$99.67M to -$127.57M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.